The authors in this study explored the relationship between self-care agency and quality of life in patients with benign prostatic hyperplasia. A convenience sample of 157 patients was interviewed. The levels of both self-care agency and quality of life were close to the mean. Pearson correlation analysis demonstrated that quality of life was positively correlated with self-care agency and the self-care subgroups of abilities, responsibility, esteem, and evaluation. Improved self-care agency and the four subscale items could enhance quality of life. Intervention programs for benign prostatic hyperplasia patients must emphasize self-care agency so as to improve their health behavior and quality of life.
AlcarazA.Carballido-RodríguezJ.Unda-UrzaizM.Medina-LópezR.Ruiz-CerdáJ. L.Rodríguez-RubioF.. . . ManasanchJ. (2016). Quality of life in patients with lower urinary tract symptoms associated with BPH: Change over time in real-life practice according to treatment-the QUALIPROST study. International Urology and Nephrology, 48, 645–656.
2.
BerryS. J.CoffeyD. S.WalshP. C.EwingL. L. (1984). The development of human benign prostatic hyperplasia with age. Journal of Urology, 132, 474–479.
3.
CarboneA.FuschiA.Al RawashdahS. F.Al SalhiY.VelottiG.RipoliA.. . . PastoreA. L. (2016). Management of lower urinary tract symptoms associated with benign prostatic hyperplasia in elderly patients with a new diagnostic, therapeutic and care pathway. International Journal of Clinical Practice, 70, 734–743.
4.
Department of Veterans Affairs. (1993). A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia: The Department of Veterans Affairs cooperative study of transurethral resection for benign prostatic hyperplasia. Journal of Urology, 150, 1696–1700.
5.
DonovanJ. A. (1996). The ICS-BPH study: The psychometric validity and reliability of the ICS male questionnaire. Urology, 77, 554–562.
6.
ErkocM.OtunctemurA.BesirogluH.AltunrendeF. (2018). Evaluation of quality of life in patients undergoing surgery for benign prostatic hyperplasia. Aging Male, 21(4), 1–5.
7.
EversG. C.IsenbergM. A.PhilipsenH.SentenM.BrounsG. (1993). Validity testing of the Dutch translation of the appraisal of the self-care agency A.S.A.-scale. International Journal of Nursing Studies, 30, 331–342.
8.
FangJ. (2014). Quality of life determination method and its application. Beijing Shi, China: Beijing Medical University.
9.
HakimiZ.HerdmanM.PavesiM.DevlinN.NazirJ.HoyleC.OdeyemiI. A. (2017). Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia. Quality of Life Research, 26, 1187–1195.
10.
Hasanpour-DehkordiA.MohammadiN.Nikbakht-NasrabadiA. (2016). Re-designing Orem’s self-care theory for patients with chronic hepatitis. Indian Journal of Palliative Care, 22, 395–401.
11.
HunterD. J.McKeeM.BlackN. A. (1995). Health status and quality of life of British men with lower urinary tract symptoms: Results from the SF-36. Urology, 45, 962–971.
12.
LukkarinenM.HentinenM. (1997). Self-care agency and factors related to this agency among patients with coronary heart disease. International Journal of Nursing Studies, 34, 295–333.
13.
MarksL. S.RoehrbornC. G.AndrioleG. L. (2006). Prevention of benign prostatic hyperplasia disease. Journal of Urology, 176, 1299–1306.
14.
OremD. E. (2001). Nursing: Concepts of practice (6th ed.). St. Louis, MO: Mosby.
15.
WangH. H.LaffreyS. C. (2000). Preliminary development and testing of instruments to measure self-care agency and social support of women in Taiwan. Kaohsiungy Journal of Medical Science, 16, 459–467.
16.
YangY. J.KohJ. S.KoH. J.ChoK. J.KimJ. C.LeeS. J.PaeC. U. (2014). The influence of depression, anxiety and somatization on the clinical symptoms and treatment response in patients with symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Journal of Korean Medical Science, 29, 1145–1151.
17.
YinZ.YangJ. R.RaoJ. M.SongW.ZhouK. Q. (2015). Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men. Asian Journal of Andrology, 17, 826–830.
18.
YokoyamaO.IgawaY.TakedaM.YamaguchiT.MurakamiM.ViktrupL. (2015). Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A review of clinical data in Asian men and an update on the mechanism of action. Therapeutic Advances in Urology, 7, 249–264.
19.
ZhangG. (2015). Effects of health rehabilitation on the self-care ability of elderly patients with benign prostatic hyperplasia. Journal of Modern Clinical Nursing, 23, 65–67.
